Inactive Instrument

Highlights MEDH ACQU

Equities

MTAC

US58507N1054

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

MedTech Acquisition, TriSalus Life Sciences Complete Merger	10/08/23	MT
Trisalus Life Sciences Inc. completed the acquisition of MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others.	09/08/23	CI
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	02/08/23	CI
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases At the Asco 2023 Annual Meeting	12/06/23	CI
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
MEDTECH ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	22/03/23	AQ
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncologyâ„¢ (PERIOâ„¢) Clinical Trial Progress and Pre-clinical Research Developments	15/12/22	CI
MedTech Acquisition : List of Participants - Form 8-K	14/11/22	PU
TriSalus Life Sciences to Merge With MedTech Acquisition to Go Public	14/11/22	MT
MedTech Acquisition : TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation - Form 8-K	14/11/22	PU
Trisalus Life Sciences Inc. entered into a definitive merger agreement to acquire MedTech Acquisition Corporation from Medtech Acquisition Sponsor LLC, Magnetar Financial LLC and others for $220 million in a reverse merger transaction.	13/11/22	CI
MEDTECH ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/22	AQ
MedTech Acquisition Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
MEDTECH ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/08/22	AQ
MedTech Acquisition Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	10/08/22	CI
MEDTECH ACQUISITION CORP Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	11/05/22	AQ
MedTech Acquisition Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	11/05/22	CI
MedTech Acquisition : and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination - Form 8-K	10/03/22	PU
MedTech Acquisition, Memic Innovative Surgery Agree to Terminate Merger Agreement	10/03/22	MT
MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination	10/03/22	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights MEDH ACQU

Equities

MTAC

US58507N1054

Highlights

Filters